{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:09:46Z","timestamp":1789754986714,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002655"],"award-info":[{"award-number":["82002655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52372269"],"award-info":[{"award-number":["52372269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0105"],"award-info":[{"award-number":["2023YFS0105"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025YFMS0020"],"award-info":[{"award-number":["2025YFMS0020"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.actbio.2026.09.012","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:29Z","timestamp":1788503549000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microneedle patch integrated with hydroxyapatite nanoparticles and abemaciclib for treatment of meningioma"],"prefix":"10.1016","author":[{"given":"Haibo","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3273-7544","authenticated-orcid":false,"given":"Qingqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5173-0757","authenticated-orcid":false,"given":"Xin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7400-9900","authenticated-orcid":false,"given":"Xiangfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-3333","authenticated-orcid":false,"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.actbio.2026.09.012_bib0001","article-title":"CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neurooncology"},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0002","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0003","first-page":"165","article-title":"Primary brain and other central nervous system tumors in the United States (2014-2018): a summary of the CBTRUS statistical report for clinicians","volume":"9","author":"Low","year":"2022","journal-title":"Neurooncol. Pract."},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2026.09.012_bib0004","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","article-title":"Imaging and diagnostic advances for intracranial meningiomas","volume":"21","author":"Huang","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0005","article-title":"Epidemiology of meningiomas","volume":"169","author":"Walsh","year":"2020","journal-title":"Handb. Clin. Neurol."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0006","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2026.09.012_bib0007","doi-asserted-by":"crossref","first-page":"i18","DOI":"10.1093\/neuonc\/noy136","article-title":"Advances in multidisciplinary therapy for meningiomas","volume":"21","author":"Brastianos","year":"2019","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.actbio.2026.09.012_bib0008","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41591-023-02586-z","article-title":"Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses","volume":"29","author":"Chen","year":"2023","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0009","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/cancers13112664","article-title":"Advances in multidisciplinary management of skull base meningiomas","volume":"13","author":"Ius","year":"2021","journal-title":"Cancers"},{"issue":"Suppl 1","key":"10.1016\/j.actbio.2026.09.012_bib0010","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-0038-1636502","article-title":"Meningiomas: overview and new directions in therapy","volume":"38","author":"Wang","year":"2018","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.addr.2012.08.011","article-title":"Inorganic nanosystems for therapeutic delivery: status and prospects","volume":"65","author":"Kim","year":"2013","journal-title":"Adv. Drug Deliver. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jnn.2017.12932","article-title":"Inorganic nano-targeted drugs delivery system and its application of platinum-based anticancer drugs","volume":"17","author":"Chen","year":"2017","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"10","key":"10.1016\/j.actbio.2026.09.012_bib0014","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/acsabm.3c00458","article-title":"Advancement in Biopolymer assisted cancer theranostics","volume":"6","author":"Bhattacharya","year":"2023","journal-title":"ACS. Appl. Bio Mater."},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax6946","article-title":"Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.09.012_bib0016","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.msec.2019.02.030","article-title":"Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles","volume":"99","author":"Lee","year":"2019","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"18","key":"10.1016\/j.actbio.2026.09.012_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202007672","article-title":"Synergistic combination of bioactive hydroxyapatite nanoparticles and the chemotherapeutic doxorubicin to overcome tumor multidrug resistance","volume":"17","author":"Dong","year":"2021","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2018.04.029","article-title":"Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features","volume":"544","author":"Munir","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.09.012_bib0019","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2147\/IJN.S360670","article-title":"Synthesis, characterization, functionalization and bio-applications of hydroxyapatite nanomaterials: an overview","volume":"Volume 17","author":"Munir","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2026.09.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103013","article-title":"Hydroxyapatite: a journey from biomaterials to advanced functional materials","volume":"321","author":"Mondal","year":"2023","journal-title":"Adv. Colloid. Interfac. Sci."},{"key":"10.1016\/j.actbio.2026.09.012_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111227","article-title":"Multifunctional hydroxyapatite with potential for application in theranostic nanomedicine","volume":"116","author":"Barbosa","year":"2020","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.actbio.2026.09.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120253","article-title":"Hierarchically constructed selenium-doped bone-mimetic nanoparticles promote ROS-mediated autophagy and apoptosis for bone tumor inhibition","volume":"257","author":"Li","year":"2020","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0023","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1166\/jnn.2013.7135","article-title":"Preparation and characterization of nano-hydroxyapatite nanomaterials for liver cancer cell treatment","volume":"13","author":"Ezhaveni","year":"2013","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0024","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1248\/bpb.30.128","article-title":"Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells","volume":"30","author":"Chen","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.actbio.2026.09.012_bib0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.msec.2014.03.022","article-title":"Effect of hydroxyapatite particle size, morphology and crystallinity on proliferation of colon cancer HCT116 cells","volume":"39","author":"Dey","year":"2014","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0026","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1007\/s12274-020-2817-6","article-title":"A systematic assessment of hydroxyapatite nanoparticles used in the treatment of melanoma","volume":"13","author":"Li","year":"2020","journal-title":"Nano Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10856-013-5126-8","article-title":"The inhibition of lamellar hydroxyapatite and lamellar magnetic hydroxyapatite on the migration and adhesion of breast cancer cells","volume":"25","author":"Jin","year":"2014","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0028","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1021\/acsami.0c20060","article-title":"Activation and monitoring of mtDNA damage in cancer cells via the \"proton-triggered\" decomposition of an ultrathin nanosheet","volume":"13","author":"Liu","year":"2021","journal-title":"ACS. Appl. Mater. Interfac."},{"issue":"31","key":"10.1016\/j.actbio.2026.09.012_bib0029","doi-asserted-by":"crossref","first-page":"37665","DOI":"10.1021\/acsami.1c09852","article-title":"Glucose-targeted hydroxyapatite\/indocyanine green hybrid nanoparticles for collaborative tumor therapy","volume":"13","author":"Cheng","year":"2021","journal-title":"ACS. Appl. Mater. Interfac."},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0030","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1021\/acsnano.8b01996","article-title":"Antitumor effect by hydroxyapatite nanospheres: activation of mitochondria-dependent apoptosis and negative regulation of phosphatidylinositol-3-kinase\/protein Kinase B pathway","volume":"12","author":"Zhao","year":"2018","journal-title":"ACS. Nano."},{"issue":"7","key":"10.1016\/j.actbio.2026.09.012_bib0031","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1021\/acsnano.9b01271","article-title":"Rod-scale design strategies for immune-targeted delivery system toward cancer immunotherapy","volume":"13","author":"Wang","year":"2019","journal-title":"ACS. Nano."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0032","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biomaterials.2009.09.088","article-title":"Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells","volume":"31","author":"Yuan","year":"2010","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.actbio.2026.09.012_bib0033","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1039\/C7RA01008G","article-title":"Oxidative stress-induced apoptosis of osteoblastic MC3T3-E1 cells by hydroxyapatite nanoparticles through lysosomal and mitochondrial pathways","volume":"7","author":"Jin","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.actbio.2026.09.012_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.actbio.2017.01.059","article-title":"Role of biphasic calcium phosphate ceramic-mediated secretion of signaling molecules by macrophages in migration and osteoblastic differentiation of MSCs","volume":"51","author":"Wang","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.09.012_bib0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.actbio.2023.04.027","article-title":"Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization","volume":"164","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.09.012_bib0036","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.actbio.2023.08.046","article-title":"Aspect ratio-dependent dual-regulation of the tumor immune microenvironment against osteosarcoma by hydroxyapatite nanoparticles","volume":"170","author":"Wu","year":"2023","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.actbio.2026.09.012_bib0037","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.3390\/ijms22094454","article-title":"Nanohydroxyapatite as a biomaterial for peripheral nerve regeneration after mechanical damage-In vitro study","volume":"22","author":"Wiatrak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6577","key":"10.1016\/j.actbio.2026.09.012_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1495","article-title":"CDK4 and CDK6 kinases: from basic science to cancer therapy","volume":"375","author":"Fassl","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0039","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","article-title":"Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas","volume":"146","author":"Wang","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-023-02543-7","article-title":"Even heterozygous loss of CDKN2A\/B greatly accelerates recurrence in aggressive meningioma","volume":"145","author":"Khan","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.actbio.2026.09.012_bib0041","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jamaoncol.2015.4701","article-title":"Palbociclib (PD0332991)-a selective and potent cyclin-dependent kinase inhibitor: a review of pharmacodynamics and clinical development","volume":"2","author":"Clark","year":"2016","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0042","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0365","article-title":"Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and meta-analysis","volume":"30","author":"Zhang","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.actbio.2026.09.012_bib0043","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"CDK inhibitors from past to present: a new wave of cancer therapy","volume":"88","author":"Mughal","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0044","article-title":"CDK4\/6 inhibition in hormone receptor-positive\/HER2-negative breast cancer: biological and clinical aspects","author":"Wekking","year":"2023","journal-title":"Cytokin. Growth Fact. Rev."},{"issue":"10226","key":"10.1016\/j.actbio.2026.09.012_bib0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(20)30165-3","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future","volume":"395","author":"Spring","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0046","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12032-014-0439-0","article-title":"Overexpression of cyclin D1 in meningioma is associated with malignancy grade and causes abnormalities in apoptosis, invasion and cell cycle progression","volume":"32","author":"Cheng","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.931371","article-title":"CDK 4\/6 inhibitors for the treatment of meningioma","volume":"12","author":"Young","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0048","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s12094-020-02341-7","article-title":"Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations","volume":"22","author":"Das","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0049","article-title":"The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma","volume":"3","author":"Horbinski","year":"2021","journal-title":"Neurooncol. Adv."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188912","article-title":"Immunomodulatory effects of CDK4\/6 inhibitors","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0051","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12967-022-03400-z","article-title":"CDK4\/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"7668","key":"10.1016\/j.actbio.2026.09.012_bib0052","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0053","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/s41467-020-16588-9","article-title":"Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4\/6 inhibition","volume":"11","author":"Stopfer","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0054","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s44222-023-00141-6","article-title":"Microneedle biomedical devices","volume":"2","author":"Zheng","year":"2024","journal-title":"Nat. Rev. Bioengineering"},{"key":"10.1016\/j.actbio.2026.09.012_bib0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: a smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0056","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13346-021-00922-9","article-title":"Non-dermal applications of microneedle drug delivery systems","volume":"12","author":"Panda","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2026.09.012_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135475","article-title":"A dissolving microneedle patch for Antibiotic\/Enzymolysis\/photothermal triple therapy against bacteria and their biofilms","volume":"437","author":"Yu","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"10","key":"10.1016\/j.actbio.2026.09.012_bib0058","doi-asserted-by":"crossref","first-page":"17298","DOI":"10.1021\/acsnano.2c08098","article-title":"A microneedle patch with self-oxygenation and glutathione depletion for repeatable photodynamic therapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS. Nano."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0059","article-title":"Silk microneedle patch capable of on-demand multidrug delivery to the brain for glioblastoma treatment","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater. Weinheim."},{"key":"10.1016\/j.actbio.2026.09.012_bib0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jconrel.2021.08.057","article-title":"Microneedle-mediated vascular endothelial growth factor delivery promotes angiogenesis and functional recovery after stroke","volume":"338","author":"Liu","year":"2021","journal-title":"J. Control Releas."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0061","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-020-03410-1","article-title":"Implantation of carmustine wafers (Gliadel\u00ae) for high-grade glioma treatment. A 9-year nationwide retrospective study","volume":"147","author":"Champeaux","year":"2020","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0062","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biomaterials.2015.08.045","article-title":"Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels","volume":"73","author":"Yue","year":"2015","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801054","article-title":"Biodegradable gelatin methacryloyl microneedles for transdermal drug delivery","volume":"8","author":"Luo","year":"2019","journal-title":"Adv. Healthcare Mater."},{"issue":"32","key":"10.1016\/j.actbio.2026.09.012_bib0064","doi-asserted-by":"crossref","first-page":"16724","DOI":"10.1039\/D0NR02759F","article-title":"Biodegradable microneedle patch for transdermal gene delivery","volume":"12","author":"Qu","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.09.012_bib0066","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2024.01.013","article-title":"Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment","volume":"366","author":"Ruan","year":"2024","journal-title":"J. Contr. Releas."},{"key":"10.1016\/j.actbio.2026.09.012_bib0067","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jconrel.2022.06.028","article-title":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure prophylaxis","volume":"348","author":"Volpe-Zanutto","year":"2022","journal-title":"J. Contr. Releas."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0068","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.actbio.2009.10.032","article-title":"Effect of phase composition and microstructure of calcium phosphate ceramic particles on protein adsorption","volume":"6","author":"Zhu","year":"2010","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000527","article-title":"Biodegradable \u03b2-cyclodextrin conjugated gelatin methacryloyl microneedle for delivery of water-insoluble drug","volume":"9","author":"Zhou","year":"2020","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0071","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"EdgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.actbio.2026.09.012_bib0072","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"ClusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.actbio.2026.09.012_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613530","article-title":"Immunoglobulin expression in cancer cells and its critical roles in tumorigenesis","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0074","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41423-019-0327-9","article-title":"Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells","volume":"17","author":"Wang","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/polym8080269","article-title":"3D Culture of chondrocytes in gelatin hydrogels with different stiffness","volume":"8","author":"Li","year":"2016","journal-title":"Polymers"},{"issue":"5","key":"10.1016\/j.actbio.2026.09.012_bib0076","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neurol.2023.03.006","article-title":"Innovative treatments for meningiomas","volume":"179","author":"Graillon","year":"2023","journal-title":"Rev. Neurol."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0077","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14737175.2023.2254498","article-title":"Advances in the systemic therapy for recurrent meningiomas and the challenges ahead","volume":"23","author":"Li","year":"2023","journal-title":"Expert. Rev. NeurOther"},{"issue":"20","key":"10.1016\/j.actbio.2026.09.012_bib0078","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.3390\/cancers14205038","article-title":"Long-term follow-up, treatment strategies, functional outcome, and health-related quality of life after surgery for WHO grade 2 and 3 intracranial meningiomas","volume":"14","author":"Pettersson-Segerlind","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.actbio.2026.09.012_bib0079","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cancers15020483","article-title":"The role of pharmacotherapy in treatment of meningioma: a systematic review","volume":"15","author":"Shahbandi","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.actbio.2026.09.012_bib0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","article-title":"Emerging systemic treatment options in meningioma","volume":"161","author":"Mair","year":"2023","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.actbio.2026.09.012_bib0081","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41591-024-03001-x","article-title":"Refining neoadjuvant immunotherapy for resectable lung cancer","volume":"30","author":"Shields","year":"2024","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0082","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","article-title":"Mechanisms of immune activation and regulation: lessons from melanoma","volume":"22","author":"Kalaora","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0083","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.actbio.2026.09.012_bib0084","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2016.03.009","article-title":"CD4+CD25+ regulatory T cells in tumor immunity","volume":"34","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0086","doi-asserted-by":"crossref","first-page":"10731","DOI":"10.2147\/CMAR.S228887","article-title":"T-regulatory cells In tumor progression and therapy","volume":"Volume 11","author":"Verma","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.09.012_bib0087","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0394632017730241","article-title":"Innate immunity may play a role in growth and relapse of chordoid meningioma","volume":"30","author":"Presta","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0088","unstructured":"Hideki, A. and O. Masataka, Effect of adracin-adsorbing HAP-sol on Ca-9 cell growth. 1993."},{"key":"10.1016\/j.actbio.2026.09.012_bib0089","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1038\/srep07134","article-title":"Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo","volume":"4","author":"Han","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.09.012_bib0090","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.2147\/IJN.S33584","article-title":"Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo","volume":"7","author":"Chu","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.actbio.2026.09.012_bib0091","first-page":"4080","article-title":"Nano hydroxyapatite induces glioma cell apoptosis by suppressing NF-\u03bab signaling pathway","volume":"17","author":"Guo","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"7874","key":"10.1016\/j.actbio.2026.09.012_bib0092","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0093","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/noac224","article-title":"Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features","volume":"25","author":"Choudhury","year":"2023","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2026.09.012_bib0094","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/neuonc\/noab155","article-title":"Newly established patient-derived organoid model of intracranial meningioma","volume":"23","author":"Yamazaki","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113676","article-title":"Multiple effects of CDK4\/6 inhibition in cancer: from cell cycle arrest to immunomodulation","volume":"170","author":"Bonelli","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0096","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231205848","article-title":"CDK4\/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity - a narrative review","volume":"15","author":"Pavlovic","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1272602","article-title":"Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4\/6 inhibitors beyond progression","volume":"13","author":"Horani","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0098","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-031-29750-2_16","article-title":"Novel medical therapies in meningiomas","volume":"1416","author":"Danish","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0099","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-031-29750-2_17","article-title":"Immunotherapy for Meningiomas","volume":"1416","author":"Wirsching","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.actbio.2026.09.012_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306222","article-title":"Advances in the application of microneedles in the treatment of local organ diseases","volume":"20","author":"Li","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.actbio.2026.09.012_bib0101","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jconrel.2023.07.023","article-title":"Microneedle-enabled therapeutics delivery and biosensing in clinical trials","volume":"360","author":"Zhang","year":"2023","journal-title":"J. Contr. Rel."},{"issue":"3","key":"10.1016\/j.actbio.2026.09.012_bib0102","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10544-023-00658-y","article-title":"Microneedles: materials, fabrication, and biomedical applications","volume":"25","author":"Luo","year":"2023","journal-title":"Biomed. Microdevic."},{"issue":"1","key":"10.1016\/j.actbio.2026.09.012_bib0103","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301068","article-title":"Recent advances in bioelectronics for localized drug delivery","volume":"8","author":"Jiang","year":"2024","journal-title":"Small. Meth."},{"key":"10.1016\/j.actbio.2026.09.012_bib0104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejpb.2022.11.016","article-title":"Development of nanoparticle loaded microneedles for drug delivery to a brain tumour resection site","volume":"182","author":"Muresan","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.actbio.2026.09.012_bib0105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jpp\/rgad058","article-title":"The promising application of hydrogel microneedles in medical application","volume":"75","author":"Wu","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.actbio.2026.09.012_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121500","article-title":"Cyclodextrins and derivatives in drug delivery: new developments, relevant clinical trials, and advanced products","volume":"324","author":"Kali","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.actbio.2026.09.012_bib0107","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.addr.2013.05.001","article-title":"Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliver. Rev."},{"issue":"1\u20132","key":"10.1016\/j.actbio.2026.09.012_bib0108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2026.09.012_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112758","article-title":"Cyclodextrins as an encapsulation molecular strategy for volatile organic compounds- pharmaceutical applications","volume":"218","author":"Paiva-Santos","year":"2022","journal-title":"Colloids. Surf. B Biointerfac."},{"issue":"9","key":"10.1016\/j.actbio.2026.09.012_bib0110","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3390\/pharmaceutics15092345","article-title":"Cyclodextrin inclusion complexes for improved drug bioavailability and activity: synthetic and analytical aspects","volume":"15","author":"Sarabia-Vallejo","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126005994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126005994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:40:23Z","timestamp":1789753223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126005994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":110,"alternative-id":["S1742706126005994"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.09.012","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microneedle patch integrated with hydroxyapatite nanoparticles and abemaciclib for treatment of meningioma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}